Physician profile
Terry Fletcher
NPI 1851443832
$3,227.86
in general payments reported to CMS, 2019-2025
22 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $194 · 2021: $158 · 2022: $922 · 2023: $1,488 · 2024: $73.58 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879 · Consulting Fee: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.94 |
| Consulting Fee | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Spine, LLC | $800.00 | 2023 | |
| Relievant Medsystems, INC. | $784.28 | 2022-2023 | Intracept |
| Boston Scientific Corporation | $420.69 | 2022-2024 | Wavewriter Alpha Prime 16, Intracept, Infinion 16 |
| Medtronic, INC. | $251.11 | 2021-2025 | Intellis Adaptivestim |
| Abbott Laboratories | $208.50 | 2023-2025 | Proclaim, Eterna, Octrode |
| Vertiflex, INC. | $121.77 | 2019 | |
| Stimwave Technologies Incorporated | $115.80 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $94.90 | 2021-2023 | Xtampza, Belbuca |
| Medtronic USA, INC. | $74.98 | 2020 | |
| Biodelivery Sciences International, INC. | $57.58 | 2020-2021 | |
| Abbvie INC. | $44.17 | 2022 | |
| Tersera Therapeutics LLC | $39.96 | 2019 | |
| Allergan, INC. | $37.86 | 2019 | |
| Lilly USA, LLC | $37.67 | 2019-2021 | |
| Nevro Corp. | $31.67 | 2022-2023 | Senza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $22.28 | 2025 | |
| Nalu Medical, INC. | $17.33 | 2022 | |
| Kaleo, INC. | $14.44 | 2019 | |
| Pfizer INC. | $14.38 | 2021 | |
| Daiichi Sankyo INC. | $14.25 | 2019 | |
| Bioventus LLC | $12.36 | 2020 | |
| Piramal Critical Care | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Fletcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.